Contribution of L-Tyrosine to Human Decision Making in Stressful Situations

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

April 7, 2022

Study Completion Date

April 7, 2022

Conditions
Stress, Psychological
Interventions
BIOLOGICAL

Blood collection

A blood sample will be collected before and after treatment administration

DRUG

L-Tyrosine 500 Mg

The participants will be administered 4 capsules of L-Tyrosine 500 mg per oral route

DRUG

Placebo

The participants will be administered 4 capsules of Lactose 500 mg (placebo) per oral route

BEHAVIORAL

Cognitive tasks

The participants will perform cognitive decision-making tasks: Simon task and masking task after treatment administration

OTHER

Stress exposure

Unpleasant but not painful skin stimulations will be administered to the participants at variable intervals on the left leg during the cognitive tasks

BEHAVIORAL

Anxiety scale

Spielberger's State Trait Anxiety Inventory (STAI) will be filled by the participants before and after cognitive tasks

DEVICE

Electromyography (EMG)

Electromyography measurements will be performed during cognitive tasks.

DEVICE

Electroencephalography (EEG)

Electroencephalography measurements will be performed during cognitive tasks.

Trial Locations (1)

91223

Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge

All Listed Sponsors
lead

Direction Centrale du Service de Santé des Armées

OTHER

NCT04518254 - Contribution of L-Tyrosine to Human Decision Making in Stressful Situations | Biotech Hunter | Biotech Hunter